Beneficial effects of terlipressin in hepatorenal syndrome: A prospective, randomized placebo‐controlled clinical trial

Solanki, Prashant; Chawla, Atul; Garg, Ramesh; Gupta, Rajiv; Jain, Monika; Kumar Sarin, Shiv

doi:10.1046/j.1440-1746.2003.02934.x

Public

Beneficial effects of terlipressin in hepatorenal syndrome: A prospective, randomized placebo‐controlled clinical trial

Published in Journal of Gastroenterology and Hepatology • Jan 24, 2003

Authors:

Prashant Solanki

Atul Chawla

Ramesh Garg

Abstract

BACKGROUND AND AIM: Hepatorenal syndrome (HRS) occurs in about 18% of cirrhotic patients with ascites and is characterized by intense renal vasoconstriction, low glomerular filtration rate and preserved tubular function and normal renal histology. The aim of the present study was to examine the effe...

Subject

Terlipressin

Medicine

Hepatorenal syndrome

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!